Glitaray M 0.5 Tablet SR
By Glitaray M
Rx
15 Tablet SR in a Strip

Composition
Glimepiride(0.5mg) + Metformin(500mg)

Manufacturer - Lloyd Healthcare Pvt Ltd
702, Balaji Business Park, Andheri Kurla Road, Marol Naka, Andheri East, Gamdevi, Marol, Andheri East, Mumbai, Maharashtra 400059

Expires on or after
February, 2027

liver
The use of Glitaray M 0.5 Tablet SR should be approached with caution in individuals with liver disease. It may be necessary to adjust the dosage of Glitaray M 0.5 Tablet SR in such cases. It is advisable to seek guidance from a medical professional before starting this medication. Typically, treatment with Glitaray M 0.5 Tablet SR commences at a low dose for patients with mild to moderate liver conditions. However, it is not advisable to use this medication in individuals with severe liver disease. Remember to consult your doctor for personalized advice based on your specific liver health status.

kidney
Caution should be taken when using Glitaray M 0.5 Tablet SR in patients with kidney disease. Dose adjustment may be necessary, and it is not recommended for those with severe kidney issues. Regular kidney function monitoring is advised during treatment.

alcohol
It is unsafe to drink alcohol while taking Glitaray M 0.5 Tablet SR. Avoid consuming alcohol with this medication.

driving
"Caution when driving Avoid driving if experiencing symptoms of low or high blood sugar."

pregnancy
Glitaray M 0.5 Tablet SR is considered unsafe during pregnancy. Limited human studies suggest potential harm to the developing baby. Your doctor will evaluate benefits and risks before prescribing. Consult your doctor.

breastfeeding
Glitaray M 0.5 Tablet SR is not safe to use while breastfeeding, as it may cause harm to the baby due to potential toxicity.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹115
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024